Member Info for xviolet

Great investment case. must have been an infection in the lab .

nothing in the RNS about that. just make rubbish up. anything will do.

that is the investment case. make up rubbish.

if that is your investment case...make up something....that is laughable.

I think the RNS is just vague enough to stop the share price collapsing completely

If u think some people 'knew' before you did, you cannot possibly stay invested here.

and you'd have to read today's RNS in that light as well.

Time

2 go.

Thanks everyone for all the replies re the size of the pharma comp mentioned by Tim

i'll have a look at the last interview and see what I think.

but its great that 'big' is the word he used. granted its not technical or anything. for compairsion...NARF who in their recent investor meet specified the size of the mcap of potential partner comps - so they didn't just use words like 'big' or small but used words like 'billions'. which I don't think Tim used. or maybe he did. i'll have to listen.

Whenever I see the word 'deal' on this board i also see the words 'big pharma'.

tell me. in his interviews did Tim say 'deal with big pharma'. or did he say 'deal'.

because...a deal could be with a small pharma. and it could be a small deal.

in which case....well...i won't bore you.

With MB back on board

they came back to life.

if you google pareta.

Remember BRH paid more than this.

Read the old BRH RNS.

This share is tricky - we could easily get another RNS with more news.

86KB

you are very enthusiastic. i jsut cant make those kinds of jumps. yes a deal. but i just can't easily eqaute 'chunky' with billions. and come on...chunky is not a technical term in finance. its garbage. its open to interpretation. not for me. or my savings. but good luck if you are punting your savings. and to all those who are here to lead others astray...and I can't pretend I haven't done that myself....well...shame we have to do that. innit.

'the big landing'

DId the CEO specify exactly what kind of 'deal' you could expect.

And what the 'deal' would be used to fund.

Unless you know the answers to those questions you can cannot be sure that the deal will be 'big'. It might not be 'big'. It might be medium. Or small. It might come with warrants attached. But...you just don't know. So bear that in mind when you invest or post. Investing blind. Really really blind. What a great idea. And why not encourage others to do the same. Nice. Nice work.

Re 30p and multiples thereof.

still think an estimate was £1+ on succesful completion of P3 trial

at the moment - no trial happening (not even early stages). so no results to create value.

Sounds interesting

shorts closing. bad news out of the way.

then...

INC? product appears to be good. at the moment they are off-loading stock but in the future they might license it out again?

that would create considerable value. an. i'm amazed they got funding for the current program so I suspect there was something else discussed. but only a guess .

CEO takes £100K a year?

someone thinks that is well paid.

its not really. not if you are negotiating with FDA etc. but it might seem like a lot. but i don't think it is.

Fascinating. so some think its cheap enough to buy in and try and get everything going again.

I reckon they are a bit premature. When we hear from sushi again we might be closer to an entry level. not there yet IMO. but its only guesswork.

Could be avion with a small deal and 6p warrants

could be merck with a billion dollar buyout

good luck betting your life savings on those probabilities

Or lets say the Type M conditions I came across appeared to be very niche. I can't recall looking to see if there was significant pharma interest - but I did find a few accounts saying these condtions were super super niche. Granted my deep dive wasn't that deep but still...Tim needs to name the actual conditions he can treat - talk about the size of a real market - if we want to put a price on the drug/company.

Vikr

50 autoimmune diseases?

did Tim name them?

When I Google'd Type M and autoimmune diseases I ended up with one or two - and they were so niche it would mean a drug that could treat them would have such a small market that it would be of no interest to a larger phama. But perhaps Tim named some diseases in the last interviews? Other than Lupus which should keep the share price above/around 5p...what other diseases did he name?

Basically someone save me here!

I really can't recall. I just know it was good.

Actually I can't remember what the chart revealed

first gap at 1.6. that much was clear to me.

and then I can't remember. it was a while ago.

so....any chartists who are up to date on MIRI..please let us know what you think.